FDA Approved: DRONABINOL — Supplemental Application (Rhodes Pharmaceuticals L.P.)

View source ↗

Summary

The FDA approved a supplemental application for dronabinol from Rhodes Pharmaceuticals L.P., enabling a generic dronabinol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Anorexia
• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Dronabinol (dronabinol)

Snippet

SUPPL AP for DRONABINOL (DRONABINOL)